Literature DB >> 3297693

Purification and characterization of human interleukin-1 alpha produced in Escherichia coli.

P Wingfield, M Payton, P Graber, K Rose, J M Dayer, A R Shaw, U Schmeissner.   

Abstract

The production of human interleukin-1 alpha (IL-1 alpha) in Escherichia coli is described together with a method for its purification. The isolated protein was shown to be pure and physically homogeneous. The in vitro biological activity of IL-1 alpha was tested with the mononuclear-cell factor and the lymphocyte-activating factor assays. The specific activity determined with both assays was about 3 X 10(7) units mg-1 and is similar to that observed with recombinant human IL-1 beta. The purified protein was resolved by chromatofocusing into two species of isoelectric points 5.45 and 5.20 (75% and 25%, respectively, of the total protein). Both species had similar chemical properties and biological activities to the unfractionated protein. The charge difference between the species was attributed to the deamidation of a single Asn or Gln residue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297693     DOI: 10.1111/j.1432-1033.1987.tb11472.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection.

Authors:  Marcel Wüthrich; Vanessa LeBert; Kevin Galles; Jane Hu-Li; Shlomo Z Ben-Sasson; William E Paul; Bruce S Klein
Journal:  J Infect Dis       Date:  2013-06-20       Impact factor: 5.226

2.  Role of TNF and IL-1 in infections with Toxoplasma gondii.

Authors:  H R Chang; G E Grau; J C Pechère
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 4.  Overview of the purification of recombinant proteins.

Authors:  Paul T Wingfield
Journal:  Curr Protoc Protein Sci       Date:  2015-04-01

5.  Endothelial cell activation induced by tumor necrosis factor and lymphotoxin.

Authors:  D E Cavender; D Edelbaum; M Ziff
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

6.  C-terminal peptide identification by fast atom bombardment mass spectrometry.

Authors:  K Rose; L A Savoy; M G Simona; R E Offord; P Wingfield
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

7.  Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha.

Authors:  S Grenfell; N Smithers; K Miller; R Solari
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

8.  Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels.

Authors:  A Schweizer; U Feige; A Fontana; K Müller; C A Dinarello
Journal:  Agents Actions       Date:  1988-12

Review 9.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

10.  Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells.

Authors:  F Cozzolino; A Rubartelli; D Aldinucci; R Sitia; M Torcia; A Shaw; R Di Guglielmo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.